Abstract
Multi-institutional Study of Neurologic Outcomes in People with Multiple Sclerosis Who Are Treated with Immune Checkpoint Inhibitors for Oncologic Indications (PL4.004)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have